Nexalin Technology - NXL Enterprise Value-to-Revenue Multiple

Nexalin (NXL) - corporate logo

Nexalin Technology, Inc. (NXL) designs neurostimulators, outsourcing final assembly to external partners under strict medical supervision. The EV-to-revenue ratio on GURU.Markets reflects the valuation trend, where the metric remains around 7714.29. The company develops non-invasive, drug-free methods for combating anxiety while adhering to standard environmental safety regulations within its laboratories.

Nexalin Technology (NXL) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

NXL (Nexalin): analytical breakdowns and indicator data

- stock price and consensus target price:
- issuer market value details:
Initial company analysis:Nexalin - NXL
Finished products of Nexalin Technology Inc

Recurring revenues for Nexalin Technology, Inc. (NXL) from the sale of brain stimulation consumables make the Enterprise Value-to-Revenue (EV/Revenue) multiple a key indicator of investment attractiveness. This metric compares market capitalization and net debt against sales volume, allowing for a business valuation independent of financing structure and confirming the stability of the issuer's position.